Emerging Drug Candidates and Therapeutic Approaches for Ocular Disorders
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 13 September 2024 | Viewed by 156
Special Issue Editor
Interests: eyes; ocular diseases; cataracts
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, titled "Emerging Drug Candidates and Therapeutic Approaches for Ocular Disorders" extends a warm invitation to researchers and scholars from from various disciplines within the scientific community. We are seeking insightful research contributions that are dedicated to the exploration and validation of novel therapeutic targets and potential drug candidates for a wide spectrum of ocular disorders. The importance of this endeavor cannot be overstated, as eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, dry eyes, cataracts, and various others continue to exert a substantial and often debilitating impact on a global scale. Consequently, the development of innovative therapeutic strategies is a pressing need.
Manuscripts submitted for this Special Issue should ideally provide mechanistic insights, demonstrating the efficacy or safety profiles of these newfound therapeutic targets and drug candidates. We welcome a diverse range of contributions, including original research articles that unveil groundbreaking discoveries, reviews that synthesize existing knowledge, clinical studies that validate and refine these therapeutic approaches, and commentaries that offer critical perspectives and insights. Our goal is to advance the field of ophthalmology by fostering a deeper understanding of ocular disorders and by paving the way for more effective and targeted treatment options.
Dr. Hongli Wu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmology
- therapeutic targets
- pharmacokinetics
- drug development
- drug safety
- drug formulation
- cataract
- corneal disease
- glaucoma
- macular degeneration
- diabetic retinopathy
- clinical studies
